Valneva
Michael Ginzler has over two decades of work experience in the pharmaceutical industry. Michael began their career as a Research Assistant at Boehringer Ingelheim, where they focused on oncology and molecular biology research. Michael then moved to Intercell AG, where they held various roles such as Lab Manager and Validation Manager in the Quality Assurance department. In 2013, Ginzler joined Valneva as the Head of Quality Assurance and later became the Director of Quality Operations. Throughout their career, they have been involved in areas such as qualification, validation, IT-validation, and GMP certification.
Michael Ginzler attended the Federal Training and Research Institute for Industrial Chemistry from 1993 to 1997. Michael studied Biochemistry and Biotechnology, but no degree or field of study information was provided.
This person is not in any offices
Valneva
2 followers
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.